Ziopharm Oncology Names Sath Shukla as Chief Financial Officer

NEXT STORY
GeoVax Presents HIV Vaccine Study Data
PREV STORY
Chembio Diagnostics to Report Second Quarter 2019 Financial Results on August 6, 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Veterinarian Brieana Tunison Joins Emergency Animal Hospital of Northwest Austin

AUSTIN, Texas, May 31, 2015 (GLOBE NEWSWIRE) -- Emergency Animal Hospital of Northwest Austin ...

author_avatar
NASDAQ Market News

Aptose Biosciences to Participate at the Oppenheimer & Co. Inc. Boston Oncology Insight Summit and 1×1 Day

SAN DIEGO and TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) ...

author_avatar
NASDAQ Market News

SOLAR-1 trial of Novartis investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) meets primary endpoint in HR+/HER2- advanced breast cancer with PIK3CA mutation

SOLAR-1 evaluated BYL719 plus fulvestrant vs. fulvestrant alone in HR+/HER2- advanced breast cancer patients ...

author_avatar
NASDAQ Market News